Boston Scientific (BSX) has filed documents with European regulators telling them of its intent to acquire medical-device maker Guidant (GDT).
The Natick, Mass., company filed the necessary notifications with the European Commission, two weeks after submitting a similar notice to the Federal Trade Commission and the Justice Department in the U.S. Boston will buy Guidant in a $27 billion deal that values the company at $80 a share. Last month, Boston won a bidding war with Johnson & Johnson(JNJ) for Guidant. Abbott (ABT) has agreed to acquire certain Guidant businesses and share the rights to Guidant's drug-eluting stent program with Boston Scientific. Boston says its agreement with Abbott should help it secure antitrust approvals for the Guidant transaction. Boston Scientific shares rose 1.5% to $24.49, and Guidant was up 0.2% to $76.63.>To order reprints of this article, click here: ReprintsTheStreet Premium Services For Personal Service: 877-471-2967
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 12,883.95 | 1,349.96 | 2,915.86 | 19.75 |
Oil *
117.78
|
|
UP
5.75 |
UP
2.91 |
UP
11.78 |
UP
0.09 |
10 Yr
1.98%
SPDR Gold
168.50
|
|
+0.04%
|
+0.22%
|
+0.41%
|
+0.46%
|
Data delayed 20 minutes |
Connect with TheStreet